Indigenous and Culturally Responsive Psychedelic Therapy in Canada

This guide is for Indigenous patients (First Nations, Inuit, and Métis) and families thinking about clinical psychedelic-assisted therapy in Canada, and for clinicians who want to offer it with cultural humility. It explains what cultural safety means in practice, and it is honest about one thing from the start: clinical psychedelic-assisted therapy is a Western medical pathway, and it is distinct from Indigenous traditional and ceremonial healing. The two are not the same, and one is not a substitute for the other.

Medically reviewed by Jacque Lovely, RN, MN, MBA, PMP, Reg #74334 on 2026-05-28.

Hope for Wellness Helpline: 1-855-242-3310. A 24/7 Indigenous-specific crisis and counselling line, available in English, French, Cree, Ojibway, and Inuktitut. Online chat at hopeforwellness.ca. If you or someone you love is in crisis, contact Hope for Wellness, the 9-8-8 Suicide Crisis Helpline, or local emergency services. ATMA CENA is not a crisis service.

Key takeaways

• Clinical psychedelic-assisted therapy and Indigenous traditional healing are distinct. Plant medicines used in Indigenous ceremonial contexts are not the same as clinical psilocybin, MDMA, or ketamine, and they must be respected, not appropriated or treated as interchangeable.
• There are no Indigenous-specific efficacy trials. No psychedelic-therapy trial has studied a specifically Indigenous population, so this article does not make Indigenous-specific outcome claims. The general evidence base is applied honestly.
• Cultural safety and self-determination come first. You may prefer traditional healing, clinical care, both, or neither. Clinical psychedelic-assisted therapy is one option offered with humility, not a recommendation.
• Trauma-informed care matters here. The Canadian context includes residential schools, the Sixties Scoop, and intergenerational trauma. Care should be built with that history in view.
• Cultural humility is a stance, not a credential. It means lifelong self-reflection, honesty about power and limits, and partnership rather than a "competence" checklist.
• Your community relationships stay yours. If you work with an Elder, healer, or community wellness centre, that relationship is parallel to clinical care and is respected, not replaced.

If you are an Indigenous patient or family member and want a frank, no-pressure conversation about whether clinical care might fit, you can book a free information call when you are ready.

Why this guide is framed differently

Most articles about a patient population describe the group, the evidence, and the access pathways. This one needs more care than that. The history of Western medicine with Indigenous Peoples in Canada includes deep harm: residential schools, coercive medical practices in the former Indian hospital system, the Sixties Scoop, and documented racism in health care. The modern psychedelic field carries its own appropriation problem, with traditional plant medicines taken out of their ceremonial contexts and rebranded as wellness products, often without consent or benefit to source communities.

A clinical guide that named none of this would be part of the problem. So the honest stance is to be clear about three things: the history matters, the distinction between clinical therapy and traditional medicine is firm, and clinical psychedelic-assisted therapy is offered as one option, not as a replacement for anything Indigenous communities already hold.

Indigenous healing traditions are distinct from clinical psychedelic therapy

This is the distinction the whole guide rests on, so it comes first. Indigenous healing traditions, including the ceremonial use of certain plants by specific nations, are ancient, place-based, and inseparable from the languages, relationships, songs, and protocols they live within. They are sovereign cultural and spiritual practices, governed by Indigenous law and tradition, not by Health Canada.

Clinical psychedelic-assisted therapy is a different thing. In licensed Canadian clinics it uses pharmaceutical-grade compounds (ketamine and esketamine, and, where a physician initiates Health Canada's case-by-case authorization pathway, psilocybin and MDMA) given under medical supervision and paired with Western psychotherapy. The substances are not equivalent to ceremonial medicines. Pharmaceutical psilocybin accessed through that pathway is not a ceremonial mushroom; clinical MDMA is not peyote and not ayahuasca; off-label ketamine is not a traditional medicine of any nation. The molecules may overlap, but the contexts, intentions, protocols, and meanings differ [CPHA].

A clinic that blurred this line, by using ceremonial language in a clinical session, displaying sacred items as décor, or calling its work "ceremony," would be appropriating rather than honouring. Choosing clinical psychedelic-assisted therapy means accessing a Western clinical pathway. If you also work with Elders, healers, or your community's traditional medicine, that is a separate and parallel relationship that a clinic should respect but never provide, imitate, or claim.

The Canadian context: trauma-informed and honest

Mental health need among Indigenous Peoples in Canada cannot be understood apart from colonization and its ongoing effects. Residential schools operated into the 1990s, and the Truth and Reconciliation Commission described the system as cultural genocide. The Sixties Scoop removed Indigenous children from their families at scale. Intergenerational trauma, systemic racism in health care, and inequities in housing, water, food security, and access to services remain present, particularly in remote and northern communities [TRC].

The clinical implication is straightforward. Many Indigenous patients arriving at any mental-health clinic carry post-traumatic stress, depression, anxiety, and substance-use distress layered onto a historical and cultural context that conventional psychiatry was not built to understand. Trauma-informed care, which assumes that distress may be rooted in that history rather than treating it as a personal deficit, is the appropriate baseline. No clinical pathway, including psychedelic-assisted therapy, undoes intergenerational or historical trauma. Clinical work may support symptom relief, processing, and integration; the broader cultural, community, and structural work sits alongside it.

A note on evidence: No psychedelic-therapy trial has enrolled or reported results for a specifically Indigenous population. The pivotal trials in psilocybin, MDMA, and ketamine did not study Indigenous sub-groups, and researchers have noted that trial protocols have often failed to prioritize culturally safe access for Indigenous and other equity-deserving communities [Jones 2023]. This is itself a gap. Any clinic should apply the general evidence honestly and avoid implying Indigenous-specific proof that does not exist.

What cultural safety and cultural humility mean

Two ideas anchor culturally responsive clinical practice, and they are not the same.

Cultural safety moves the focus from the clinician's knowledge to the patient's experience. Care is "culturally safe" only if the patient experiences it as safe, including freedom from the racism and power imbalance that have marked Indigenous experiences of health care. The patient, not the clinician, judges whether safety was achieved.

Cultural humility (Tervalon and Murray-García 1998) is the stance that supports it: a lifelong commitment to self-reflection, an honest reckoning with power imbalance, and a posture of partnership rather than mastery [Tervalon 1998]. It is distinct from "cultural competence," which can imply a clinician becomes credentialed in another culture by completing a workshop.

In practice, cultural humility means a clinic:

• Examines its own positionality and relationship to colonial structures rather than claiming expertise in Indigenous culture.
• Builds partnership rather than substitution, and refers to or works alongside Indigenous-led services where that is the right move.
• Is honest about what it does not know and welcomes being told when its language or framing is off.
• Recognizes Indigenous knowledge as a complete way of knowing in its own right, not a supplement folded into Western medicine. The Two-Eyed Seeing principle (Etuaptmumk), articulated by Mi'kmaw Elder Albert Marshall, names this: using the strengths of Indigenous and Western knowledges together, without collapsing one into the other [TRC].

What to watch for: appropriation in the psychedelic field

You can reasonably expect an honest Canadian clinic to acknowledge the following without being asked, and you can use them to vet any provider:

• Plant-medicine appropriation. Several substances central to the modern field come from Indigenous lineages whose communities were not consulted and have not benefited.
• Cultural set-dressing. Indigenous language, imagery, songs, or ceremonial framing used in a non-Indigenous clinical setting is appropriative even when the intent is positive.
• Tokenization. Listing an Indigenous advisor without a real, ongoing, paid partnership with decision-making authority is tokenizing.
• Commodification. Selling "shamanic" retreats or ceremonies without Indigenous leadership and material reciprocity is exploitative.

Questions worth asking any clinic: Where a clinic uses any Indigenous reference, what real relationship sits behind it? What ongoing Indigenous partnerships does it maintain, and how are they structured and funded? What does the clinic explicitly decline to do, and how does it handle a request outside its scope? Will it work alongside your Elder or community wellness centre without trying to replace them? And does it claim to be Indigenous-led? An honest clinic is clear when it is not.

Accessing clinical care: the same pathways apply

There is no separate "Indigenous protocol" for clinical psychedelic-assisted therapy, and inventing one would itself be appropriative. The clinical pathway for an Indigenous patient is the same standard Canadian pathway that applies to anyone meeting clinical criteria:

• Off-label ketamine, given in-clinic under supervision (ketamine is Health Canada-approved as an anaesthetic; psychiatric use is off-label).
• Spravato (esketamine) for treatment-resistant depression, Health Canada-approved for adults under 65 (initiation is not recommended at 65 and older).
• Psilocybin and MDMA only where a physician initiates Health Canada's case-by-case authorization pathway. See the regulatory note below.

Psilocybin and MDMA are restricted drugs under Canada's Controlled Drugs and Substances Act. Legal patient access to psilocybin- or MDMA-assisted therapy requires Health Canada approval, granted on a case-by-case basis and initiated by a physician; it is not guaranteed. Such authorizations are primarily granted, for psilocybin, to adults with treatment-resistant major depressive disorder or distress associated with a life-threatening illness, and, for MDMA, to adults with PTSD [Health Canada].

Coverage follows the standard Canadian picture. The Non-Insured Health Benefits (NIHB) program, administered by Indigenous Services Canada through the First Nations and Inuit Health Branch, covers some mental-health counselling and certain medications for eligible First Nations and Inuit clients, but psychedelic-assisted therapy is not a covered NIHB benefit at this time; confirm current policy at the time of any referral [NIHB]. Métis clients are not covered by NIHB and use provincial pathways, with some Métis Nation-specific programs in certain provinces. Indigenous veterans of the Canadian Armed Forces and RCMP access the standard Veterans Affairs Canada pathway, which currently funds some ketamine but not psychedelic-assisted psychotherapy.

How your community relationships fit in

If you choose clinical care, your relationships with an Elder, healer, traditional medicine person, or community wellness program remain yours and remain central to your wellbeing. A culturally responsive clinic does not displace them. ATMA CENA's CoCare program can partner with a client's existing therapist, where that therapist has the appropriate training and a service agreement is in place, so an existing therapeutic relationship can stay involved while clinical care is provided. Whether and how any community or cultural support you choose to bring can be coordinated is best confirmed directly on an information call.

Clinical psychedelic-assisted therapy is also not the only path, and for many people it is not the first one. Community-based, Elder-led, or land-based work, with or without a clinical adjunct, is the right next step for some. An honest clinic will say so when that is its read.

What ATMA CENA offers, and what it does not

ATMA CENA is a clinical mental-health network. It offers Health Canada-regulated clinical pathways (off-label ketamine, and Spravato for treatment-resistant depression) and, where a physician initiates Health Canada's case-by-case authorization pathway, psilocybin- and MDMA-assisted therapy where clinically supported, along with comprehensive psychiatric and psychotherapy assessment and a stance of cultural humility. Its ketamine care is delivered through intranasal (Spravato and compounded), intramuscular, and oral routes; it does not provide intravenous ketamine.

ATMA CENA does not offer Indigenous traditional healing, ceremony, "shamanic" framing, Indigenous-spiritual content within clinical sessions, or any claim to teach, transmit, or commercialize Indigenous knowledge. If you are seeking traditional healing, an Elder relationship, or a ceremonial pathway, those exist within Indigenous communities and Indigenous-led organizations, and they are not what ATMA CENA provides.

Frequently asked questions

Does ATMA CENA offer Indigenous healing or ceremony?

No. ATMA CENA is a Western clinical mental-health practice. It offers clinical pathways (ketamine and Spravato, and physician-initiated, case-by-case Health Canada access to psilocybin and MDMA) within a culturally humble framework. Indigenous traditional healing is sovereign and is offered by Indigenous communities and Indigenous-led organizations, not by ATMA CENA.

Is clinical psilocybin the same as ceremonial mushrooms?

No. Pharmaceutical-grade psilocybin, accessed only where a physician initiates Health Canada's case-by-case authorization pathway, is used in a clinical session with Western psychotherapy. Ceremonial mushroom use within Indigenous traditions exists in a different cultural, spiritual, and protocol context. The molecules may overlap; the practices are distinct, and one is not a substitute for the other.

Can I keep working with my Elder or community wellness centre alongside clinical care?

Yes. Those relationships are yours and stay central. A culturally responsive clinic works alongside them rather than displacing them, where you choose to bring them into the picture. Whether and how ATMA CENA can coordinate with community or cultural supports is best confirmed directly on an information call.

Is psychedelic-assisted therapy covered by NIHB?

Not at this time. NIHB covers some mental-health counselling within limits, certain medications, and medical transportation for eligible First Nations and Inuit clients, but it does not currently cover psychedelic-assisted therapy. Coverage policy can change, so confirm at the time of any referral.

I am Métis. Does NIHB apply?

NIHB is for Status First Nations and recognized Inuit. Métis clients access provincial mental-health coverage and, in some provinces, Métis Nation-specific programs. Coverage varies by province.

I am an Indigenous veteran. Does Veterans Affairs Canada apply?

Yes. The standard VAC pathway applies. As of its current policy, VAC funds some ketamine for service-related conditions but does not fund psychedelic-assisted psychotherapy such as MDMA or psilocybin.

What is cultural safety, and how do I know if a clinic practises it?

Cultural safety means you, the patient, experience care as safe and free from racism and power imbalance; you are the judge of whether that was achieved. You can test a clinic by asking what Indigenous partnerships it maintains, what it explicitly declines to do, and how it handles requests outside its scope.

Does ATMA CENA claim to be Indigenous-led?

No. ATMA CENA is a Western clinical mental-health network. Indigenous-led organizations and clinicians exist across Canada, and anyone seeking Indigenous-led care is encouraged to access those services directly.

I am in crisis. What should I do?

Contact the Hope for Wellness Helpline at 1-855-242-3310 (24/7 Indigenous-specific crisis and counselling, in English, French, Cree, Ojibway, and Inuktitut), online chat at hopeforwellness.ca, the 9-8-8 Suicide Crisis Helpline, or local emergency services. ATMA CENA is not a crisis service.

Compliance and disclaimer

This article is educational and is not medical advice or a clinical recommendation for any individual. It does not present clinical psychedelic-assisted therapy as equivalent to, or a substitute for, Indigenous traditional or ceremonial healing, which are sovereign practices governed by Indigenous law and tradition.

Ketamine is approved by Health Canada as an anaesthetic; use for depression, anxiety, PTSD, and other mental-health indications is off-label and regulated by provincial medical regulators. Esketamine (Spravato) is Health Canada-approved for treatment-resistant depression; initiation is not recommended in patients 65 years of age and older, because efficacy was not established in that population.

Psilocybin and MDMA are restricted drugs under Canada's Controlled Drugs and Substances Act. Legal patient access to psilocybin- or MDMA-assisted therapy requires Health Canada approval, granted on a case-by-case basis and initiated by a physician; it is not guaranteed. Such authorizations are primarily granted, for psilocybin, to adults with treatment-resistant major depressive disorder or distress associated with a life-threatening illness, and, for MDMA, to adults with PTSD. No psychedelic-therapy trial has studied a specifically Indigenous population; no Indigenous-specific efficacy claims are made here. Clinical decisions belong with a qualified prescribing physician.

About the author

Reverdi Darda, RN, BScN, Reg #61707 | CEO & Founder, ATMA CENA

Reverdi Darda, RN is CEO & Founder of ATMA CENA and a Registered Nurse with over three decades of experience in healthcare operations, community engagement, policy development, and strategic planning. A recognized leader in mental health access, Reverdi has dedicated her career to advancing evidence-based treatment models and advocating for policy change that prioritizes effective care. She founded ATMA CENA to expand practitioner and public access to psychedelic-assisted therapy across Canada.

Sources

1. Truth and Reconciliation Commission of Canada (2015). Calls to Action (including health Calls 18 to 24 and Two-Eyed Seeing context). https://www2.gov.bc.ca/assets/gov/british-columbians-our-governments/indigenous-people/aboriginal-peoples-documents/calls_to_action_english2.pdf
2. Tervalon, M., Murray-García, J. (1998). Cultural humility versus cultural competence: a critical distinction in defining physician training outcomes in multicultural education. Journal of Health Care for the Poor and Underserved, 9(2):117-125. PMID: 10073197. https://pubmed.ncbi.nlm.nih.gov/10073197/
3. Jones, G. et al. (2023). Diversity, equity, and inclusion in psychedelic research and access (representation and equity-deserving-group access in psychedelic trials). Psychiatry Research. https://www.sciencedirect.com/science/article/pii/S0165178123000835
4. Canadian Public Health Association. Psychedelics and the distinction between clinical and ceremonial/traditional use (discussion document). https://www.cpha.ca/
5. Health Canada. Requests involving psychedelic-assisted psychotherapy (physician-initiated, case-by-case access pathway). https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/requests-special-access-program-psychedelic-assisted-psychotherapy.html
6. Indigenous Services Canada. Non-Insured Health Benefits (NIHB) for First Nations and Inuit. https://www.canada.ca/en/indigenous-services-canada/services/first-nations-inuit-health/non-insured-health-benefits.html
7. Indigenous Services Canada. Hope for Wellness Helpline (1-855-242-3310). https://www.hopeforwellness.ca/
8. Veterans Affairs Canada. Mental Health Benefits. https://www.veterans.gc.ca/en/financial-programs-and-services/medical-costs/coverage-services-prescriptions-and-devices/mental-health-benefits

Related articles

• Who We Serve: Psychedelic-Assisted Therapy Populations (Hub): parent hub
• Older Adults and Psychedelic-Assisted Therapy: sister population guide
• LGBTQ+ Patients and Psychedelic-Assisted Therapy: sister population guide
• CoCare: How ATMA CENA Works With Your Existing Therapist: keeping your existing relationships central

---

Last updated: 2026-05-28. This article is reviewed every 6 months.